Since Ernst Fuchs's publication on sarcoma of the uveal tract,' in which he stated that malignant melanoma does not metastasise to the eye, more than 40 cases have been reported.2-28 An autopsy series of 15 patients who had died from disseminated cutaneous malignant melanoma, and who had no ocular symptoms, showed a 33% incidence of ocular metastases. 29 The case is reported here of a man who, because of spontaneous regression of his disease, lived long enough to develop an unusual manifestation of bilateral ocular involvement in the forn of black hypopyon. Only 2 cases, both unilateral have previously been recorded.
Case history
In April 1980 a 56-year-old man presented to a dermatologist with multiple 'blue spots' which had appeared over his body in the preceding 3 months. A large black mole on his back had gradually enlarged over a period of 20 years. A clinical diagnosis of disseminated cutaneous malignant melanoma was made, which was confirmed histologically from a biopsy of a nodular lesion on the leg.
In the subsequent months several of the palpable lesions on his body became flat, leaving an area of residual melanin pigmentation. (Figs. la, lb) .
In November 1980 the patient developed a right iridocyclitis with secondary glaucoma. Because of failure to respond to treatment, the sight of this eye gradually failed. Large amounts of pigment were present in the anterior chamber, and it began to form a black hypopyon. In February 1981 a pigmented lesion was seen nasal to the disc in the left fundus. Before it was photographed vision in this eye was obscured by sudden vitreous haemorrhage. Over the next few months pigment began to accumulate in the anterior chamber of the left eye just as it had done in the right.
For these crippling catastrophes he attended his local hospital, and over a year supervened before he reattended the Westminster Hospital. He was readmitted in August 1981. Apart from his profound loss of vision his general health had remained good. The only evidence of active disease were enlarged lymph nodes in the right inguinal region, which softened and became smaller over the next 3 months. He had diffuse hyperpigmentation of the skin (melanosis cutis), most prominent on his face, which was studded with pinhead-size pigmented lesions.
Ocular findings were as follows: there was no perception of light in the right eye, with only a temporal island of light perception in the left. There was marked bulbar conjunctival and episcleral injection in both eyes. The comeas were clear but pigmented keratic precipitates were scattered over the endothelial surfaces. The lower half of the right anterior chamber and quarter of the left were filled with dark brown pigment (Figs. 2a, 2b, 2c, 3). Both pupils were completely bound down, the iris being coated with pigment. The aqueous in both eyes was a golden brown colour and there were many pigmented cells in suspension. Both lenses were opaque, with pigmented deposits on the anterior lens capsule. dense opacity in the anterior cortical vitreous. The left showed a highly mobile detached vitreous with an irregularly raised retinal surface nasal to the disc, an appearance compatible with a secondary mass (Fig. 4) .
Systemic investigations including chest and skull x-ray, CT scan of brain and orbits, liver isotope and ultrasound scans, plasma calcium, and electrolytes were all within normal limits. A skin biopsy taken in November 1981 from the lesion on the back was reported as: 'melanin pigmentation around dermal vessels with streaking of melanin in the collagen; no epidermal abnormality; appearance consistent with regressed melanoma.' Immunological investigations showed: immunoglobulins, normal; protein electrophoresis, raised alpha 1 and alpha 2 globulins; T and B cell studies showed a T lymphopenia (inducible in vitro with thymosin (TP-1) to normal); urinary melanogens, strongly positive; 24-hour urinary cysteinyl dopa, 850 gg (August 1981) 
Discussion
Because the patient was aware of his diagnosis and unwilling to undergo any invasive investigation which was not essential, no ocular paracentesis was undertaken to determine the nature of the material in his anterior chambers. It cannot therefore be definitely concluded that the ocular findings were due to secondary spread from a cutaneous primary. The history and the behaviour of the tumour rule out the possibility of an ocular primary with cutaneous secondaries. The third possibility of simultaneous bilateral choroidal melanomata and a separate primary cutaneous melanoma is equally unlikely, although 2 such cases have been described. In both instances there were predisposing factors; the B-K mole syndrome in one and ocular melanosis in the other.303' There was no evidence for such factors in this patient. On clinical grounds alone it is assumed that the ocular findings were secondary to the cutaneous disease.
There is good evidence that the melanoma was under active immunological 'attack.' A pigmented tumour was seen in the left fundus in January 1981, and this was borne out by the ultrasound findings.
There were no such findings in the right eye, but there was a dense opacity in the anterior cortical vitreous which could have been related to a secondary in the ciliary body. If it is accepted that secondary tumour was present in both eyes, it is reasonable to assume that these tumours were under the same immunological attack. It is suggested that this attack resulted in necrosis and break-up of the secondary masses, which in turn gave rise to black hypopyon, secondary glaucoma, and cataract.
Published reports give evidence to support this hypothesis. Albert et al. (1974) reported one of the only 2 previous cases of black hypopyon.32 They presented a case of disseminated cutaneous melanoma with a secondary in the ciliary body which broke up after a course of radiotherapy to form a black hypopyon. A diagnostic paracentesis showed that the hypopyon consisted of tumour cells and pigment-laden macrophages. Pathological examination of the enucleated eye revealed a necrotic tumour mass in the ciliary body with widespread dispersal of tumour cells and macrophages. Tumour cells were found invading the paracentesis track.
The other report of black hypopyon was published by Char et al. 33 They also presented a case of R. P. L. Wormald and John L. Harper The left eye is on the right. a sudden vitreous haemorrhage was interpreted as a sign of tumour reactivation. However, histopathological study showed that the haemorrhage had occurred as a result of lytic necrosis within the tumour. Reese et al. go on to explain mechanisms whereby immunocompetent lymphocytes and antibody may bring about tumour infarction by their action on the endothelium of vessels supplying the tumour. The same process might account for the sudden loss of vision in the left eye of the patient.
Iridocyclitis and secondary glaucoma are well described as presenting features of secondary intraocular melanoma.8"'-Black hypopyon may be an advanced manifestation of this phenomenon.
Finally, in considering the management of this difficult clinical problem 2 reports of uveitis and secondary glaucoma due to secondary intraocular melanoma responding to cytotoxic therapy should be mentioned.3839 It is interesting that both these cases eventually died of cerebral secondaries despite the fact that the intraocular secondaries had responded to the chemotherapy.
This report and others mentioned suggest that tumour necrosis may cause uveitis, secondary glaucoma, and even black hypopyon. Cytotoxic therapy may be more effective in treating tumour cells in aqueous suspension and causing a more gradual regression of the tumour mass. Radiotherapy may cause a more rapid tumour destruction. Our patient might have benefited from cytotoxic or immunotherapy when he first developed ocular complications. But these were withheld for fear of reducing his immunocompetence which was so effectively controlling his generalised disease.
As the life expectancy of these patients is still very poor, these considerations are theoretical. It is interesting that all 3 cases of black hypopyon reported had evidence of tumour regression, either in response to treatment or spontaneously. In future if treatment for disseminated malignant disease becomes more effective these theoretical considerations may have greater clinical relevance.
